{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:05:22Z","timestamp":1784372722107,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clinthera.2013.07.421","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T14:30:26Z","timestamp":1377181826000},"page":"1458-1473","source":"Crossref","is-referenced-by-count":19,"title":["Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Ravi K.","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowjanya","family":"Kanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.07.421_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncpgasthep0999","article-title":"Minimal hepatic encephalopathy","volume":"4","author":"Stewart","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MEG.0b013e3283417567","article-title":"Hepatic encephalopathy: from pathophysiology to therapeutic management","volume":"23","author":"Bismuth","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cld.2012.03.009","article-title":"Hepatic encephalopathy","volume":"16","author":"Khungar","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2013.07.421_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.12968\/hmed.2012.73.2.79","article-title":"Hepatic encephalopathy","volume":"73","author":"Patel","year":"2012","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.clinthera.2013.07.421_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"Haussinger","year":"2008","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2013.07.421_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2007-984576","article-title":"An algorithm for the management of hepatic encephalopathy","volume":"27","author":"Mullen","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinthera.2013.07.421_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMe1000850","article-title":"Gut flora and hepatic encephalopathy in patients with cirrhosis","volume":"362","author":"Riordan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.07.421_bib9","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00018-005-5089-0","article-title":"The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation","volume":"62","author":"Shawcross","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clinthera.2013.07.421_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199708143370707","article-title":"Treatment of hepatic encephalopathy","volume":"337","author":"Riordan","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.07.421_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1746-6342.2006.03217.x","article-title":"Review article: bacterial flora and pathogenesis in hepatic encephalopathy","volume":"25","author":"Williams","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.07.421_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.mcna.2009.03.009","article-title":"Hepatic encephalopathy: pathophysiology and emerging therapies","volume":"93","author":"Sundaram","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2013.07.421_bib13","first-page":"222","article-title":"Current concepts in the pathophysiology and management of hepatic encephalopathy","volume":"7","author":"Frederick","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2013.07.421_bib14","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S1665-2681(19)31607-2","article-title":"Minimal hepatic encephalopathy","volume":"10","author":"Zamora Nava","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11894-010-0150-z","article-title":"Advances in the evaluation and management of minimal hepatic encephalopathy","volume":"13","author":"Montgomery","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clinthera.2013.07.421_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ajg.2010.460","article-title":"Editorial: rifaximin and minimal hepatic encephalopathy","volume":"106","author":"Butterworth","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1011610427843","article-title":"Quality of life in cirrhotics with minimal hepatic encephalopathy","volume":"16","author":"Schomerus","year":"2001","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.clinthera.2013.07.421_bib20","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/A:1024784327783","article-title":"Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis","volume":"48","author":"Arguedas","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2013.07.421_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.20095","article-title":"Minimal hepatic encephalopathy impairs fitness to drive","volume":"39","author":"Wein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1572-0241.2007.01424.x","article-title":"Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations","volume":"102","author":"Bajaj","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cgh.2008.05.025","article-title":"Patients with minimal hepatic encephalopathy have poor insight into their driving skills","volume":"6","author":"Bajaj","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/hep.22032","article-title":"Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy","volume":"47","author":"Bajaj","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/cpb.2008.0242","article-title":"Impairment of driving ability and neuropsychological function in patients with MHE disease","volume":"12","author":"Kim","year":"2009","journal-title":"Cyberpsychol Behav"},{"key":"10.1016\/j.clinthera.2013.07.421_bib26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.23128","article-title":"Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ajg.2009.7","article-title":"The effect of fatigue on driving skills in patients with hepatic encephalopathy","volume":"104","author":"Bajaj","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ajg.2010.413","article-title":"Minimal hepatic encephalopathy is associated with falls","volume":"106","author":"Roman","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cld.2011.12.003","article-title":"Hepatic encephalopathy and health-related quality of life","volume":"16","author":"Bianchi","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2013.07.421_bib30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ajg.2011.154","article-title":"Minimal hepatic encephalopathy and driving: is the genie out of the bottle?","volume":"106","author":"Prakash","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib31","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1572-0241.2000.02265.x","article-title":"The prognostic significance of subclinical hepatic encephalopathy","volume":"95","author":"Hartmann","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib32","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2013.07.421_bib33","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cld.2011.12.002","article-title":"Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests)","volume":"16","author":"Kappus","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2013.07.421_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11011-012-9336-4","article-title":"Psychometric tests for diagnosing minimal hepatic encephalopathy","volume":"28","author":"Weissenborn","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.clinthera.2013.07.421_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrgastro.2010.116","article-title":"Mechanisms, diagnosis and management of hepatic encephalopathy","volume":"7","author":"Prakash","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib37","doi-asserted-by":"crossref","unstructured":"Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716\u2013721.","DOI":"10.1053\/jhep.2002.31250"},{"key":"10.1016\/j.clinthera.2013.07.421_bib38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1478-3231.2009.02009.x","article-title":"Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Randolph","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.clinthera.2013.07.421_bib40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2008.07.021","article-title":"Inhibitory control test for the diagnosis of minimal hepatic encephalopathy","volume":"135","author":"Bajaj","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib41","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2008.06.043","article-title":"Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant","volume":"135","author":"Mardini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib42","unstructured":"Overview and features of the ImPACT test. 2012. http:\/\/impacttest.com\/about\/background. Accessed April 16, 2013."},{"issue":"Suppl","key":"10.1016\/j.clinthera.2013.07.421_bib43","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0168-8278(10)60204-8","article-title":"A case control study of impact: a brief and effective web-based neuropsychological assessment battery to diagnose minimal hepatic encephalopathy (MHE)","volume":"52","author":"Tsushima","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.21586","article-title":"Value of the critical flicker frequency in patients with minimal hepatic encephalopathy","volume":"45","author":"Romero-Gomez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/jhep.2002.30957","article-title":"Critical flicker frequency for quantification of low-grade hepatic encephalopathy","volume":"35","author":"Kircheis","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib46","first-page":"27","article-title":"Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis","volume":"9","author":"Sharma","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.clinthera.2013.07.421_bib47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2007.05.019","article-title":"Assessment of low-grade hepatic encephalopathy: a critical analysis","volume":"47","author":"Kircheis","year":"2007","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.07.421_bib48","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.14309\/00000434-201210001-00456","article-title":"Does inhibitory control test (ICT) diagnose minimal hepatic encephalopathy (MHE)?","volume":"107","author":"Allampati","year":"2012","journal-title":"Am J Gastroenterol Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.07.421_bib49","first-page":"S194","article-title":"Effect of computer literacy on psychometric test performance in the diagnosis of minimal hepatic encephalopathy","volume":"107","author":"Karanth","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.21515","article-title":"Testing for minimal hepatic encephalopathy in the United States: an AASLD survey","volume":"45","author":"Bajaj","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib51","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2013.07.421_bib52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","article-title":"An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy","volume":"20","author":"Sharma","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib53","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib54","first-page":"215","article-title":"Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis","volume":"52","author":"Lata","year":"2006","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.clinthera.2013.07.421_bib55","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib56","first-page":"128","article-title":"A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy","volume":"32","author":"Saji","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11894-012-0301-5","article-title":"Quality of life in cirrhosis","volume":"15","author":"Loria","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clinthera.2013.07.421_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2036.2009.04061.x","article-title":"Predictors of health-related quality of life in patients with chronic liver disease","volume":"30","author":"Afendy","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.07.421_bib59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial)","volume":"106","author":"Sidhu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2010.08.061","article-title":"Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy","volume":"140","author":"Bajaj","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib61","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","article-title":"Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy","volume":"33","author":"Shukla","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.07.421_bib62","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy","volume":"96","author":"Blei","year":"2001","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.clinthera.2013.07.421_bib63","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/MEG.0b013e32834d1938","article-title":"Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis","volume":"23","author":"Luo","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib64","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ajg.2012.113","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy","volume":"107","author":"Agrawal","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib65","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.510260606","article-title":"Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy","volume":"26","author":"Watanabe","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0168-8278(89)90009-3","article-title":"Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study","volume":"8","author":"Morgan","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib67","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1023\/A:1005556826152","article-title":"Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy","volume":"45","author":"Dhiman","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2013.07.421_bib68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2036.1997.118289000.x","article-title":"Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy","volume":"11","author":"Horsmans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.07.421_bib69","first-page":"1126","article-title":"Effects of lactulose treatment on the course of subclinical hepatic encephalopathy","volume":"83","author":"Zeng","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.07.421_bib70","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.14309\/00000434-201010001-00279","article-title":"Primary prophylaxis of hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose","volume":"105","author":"Sharma","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.07.421_bib72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"Leevy","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.07.421_bib73","doi-asserted-by":"crossref","first-page":"S950","DOI":"10.1016\/S0016-5085(12)63683-X","article-title":"Overt hepatic encephalopathy in cirrhosis: influence of multiple clinical precipitants resulting in hospitalization","volume":"142","author":"Pantham","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib74","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1080\/00365520600825117","article-title":"Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life","volume":"41","author":"Kalaitzakis","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib75","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3748\/wjg.v16.i27.3347","article-title":"Changing face of hepatic encephalopathy: role of inflammation and oxidative stress","volume":"16","author":"Seyan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib76","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/jac\/dkq345","article-title":"Rifaximin modulates the colonic microbiota of patients with Crohn\u2019s disease: an in vitro approach using a continuous culture colonic model system","volume":"65","author":"Maccaferri","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2013.07.421_bib77","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2013.07.421_bib78","unstructured":"Xifaxan (rifaximin) tablets [package insert]. Raleigh, NC: Salix Pharmaceuticals, Inc; 2012."},{"key":"10.1016\/j.clinthera.2013.07.421_bib79","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/egh.10.78","article-title":"Rifaximin for the treatment of hepatic encephalopathy","volume":"4","author":"Mullen","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib80","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2002.14.3.290","article-title":"Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis","volume":"14","author":"Brigidi","year":"2002","journal-title":"J Chemother"},{"key":"10.1016\/j.clinthera.2013.07.421_bib81","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea","volume":"142","author":"DuPont","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.07.421_bib82","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.07.421_bib83","first-page":"387","article-title":"A non-absorbable rifamycin for treatment of hepatic encephalopathy","volume":"11","author":"Testa","year":"1985","journal-title":"Drugs Exp Clin Res"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2013.07.421_bib84","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S0168-8278(10)60515-6","article-title":"Double-blinded crossover trial analyzing the usefulness of rifaxamin in the treatment of minimal hepatic encephalopathy (MHE): an interim analysis","volume":"52","author":"Grande","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib85","unstructured":"Healthcare Cost & Utilization Project (HCUP). 2012. http:\/\/www.ahrq.gov\/data\/hcup\/. Accessed March 22, 2012."},{"key":"10.1016\/j.clinthera.2013.07.421_bib86","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcrc.2009.01.008","article-title":"Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy","volume":"24","author":"Fichet","year":"2009","journal-title":"J Crit Care"},{"key":"10.1016\/j.clinthera.2013.07.421_bib87","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2013.07.421_bib88","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/S0168-8278(10)60463-1","article-title":"Incomplete reversal of cognitive dysfunction after liver transplantation in individuals who had had overt hepatic encephalopathy before liver transplantation","volume":"52","author":"Campagna","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/lt.22197","article-title":"Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume","volume":"17","author":"Garcia-Martinez","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2013.07.421_bib90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cgh.2010.10.002","article-title":"Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy","volume":"9","author":"Riggio","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib91","first-page":"544","article-title":"Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?","volume":"94","author":"Quero Guillen","year":"2002","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.clinthera.2013.07.421_bib92","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1586\/17474124.2.6.785","article-title":"Management options for minimal hepatic encephalopathy","volume":"2","author":"Bajaj","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.07.421_bib93","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2004.11.028","article-title":"Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations","volume":"42","author":"Ortiz","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2013.07.421_bib94","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.25507","article-title":"Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis","volume":"55","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib95","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.25583","article-title":"Attention: minimal hepatic encephalopathy and road accidents","volume":"55","author":"Amodio","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.07.421_bib96","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813008114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813008114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:59:19Z","timestamp":1715907559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813008114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0149291813008114"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.07.421","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}